Determine efficacy and safety profile of any new experimental compound in murine models of influenza a and B infection in mouse models for established lethal and non‐lethal murine challenge models…
Ended Awarded Last action
- Contract number
- HHSN27200004
- Awardee
-
University Of Louisville UEI E1KJM4T54MK6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $14,014.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Louisville, KY 40202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$18,327 | |
| Original award | $18,327 |
About this award
This is a firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Louisville's Office of Research & Innovation division. The contract, valued at $14,014, is to determine the efficacy and safety profile of new experimental compounds in mouse models of influenza A and B infection. The contract was issued under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. As a prime contractor, the University of Louisville has also received other federal contract awards and grants from agencies like the Department of Veterans Affairs and Department of the Army to provide medical services and educational programming.
Description
Determine efficacy and safety profile of any new experimental compound in murine models of influenza a and B infection in mouse models for established lethal and non‐lethal murine challenge models suitable for therapeutics research in evaluating the spectrum of antiviral activity of new compounds
Quick answers
Who was awarded contract HHSN27200004?
HHSN27200004 was awarded to University Of Louisville by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 14, 2015.
How much is contract HHSN27200004 worth?
The government has obligated $0 on HHSN27200004. Its potential value, with all options, is $14,014.
Is contract HHSN27200004 an order under another contract?
Yes. HHSN27200004 is a delivery order under HHSN272201000033I, an indefinite delivery contract, on NIAID Animal Models of Infectious Diseases 2010-2017.
Was contract HHSN27200004 competed?
The extent of competition for HHSN27200004 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award